Dr. Amanda Lewis -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Amanda Lewis, a Pulmonology physician based in City, VA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Amanda Lewis has received $911.28 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Amanda Lewis has received a total of $911.28 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $911.28 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Amanda Lewis's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription

The largest payment category for Dr. Amanda Lewis is Speaking & Education, accounting for 0% ($0.00) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Amanda Lewis. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Merck & Co$911.281

Dr. Amanda Lewis has a financial relationship with Merck & Co, receiving $911.28 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Amanda Lewis. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Amanda Lewis's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Amanda Lewis has received $911.28 across 1 pharmaceutical payments as a Pulmonology physician in City, VA. Top paying companies include Merck & Co ($911.28). Dr. Lewis received a single payment of $911 in 2025. This payment originated entirely from Merck & Co. The payment was categorized as 'general' and was associated with the drug Mounjaro.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Amanda Lewis is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers may wish to inquire about any potential influence on treatment decisions given the singular source of pharmaceutical payments. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Amanda Lewis Compares to Other Pulmonology Physicians

Compared to other Pulmonologists, Dr. Lewis's payment profile is less diverse, with a single payment from one company.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Amanda Lewis in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Merck & Co$911.28generalMounjaro2025-07-12Not Assessed

Frequently Asked Questions About Dr. Amanda Lewis's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Amanda Lewis received?

Amanda Lewis has received a total of $911.28 across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Amanda Lewis taking too much pharma money?

Amanda Lewis has received $911.28 in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Pulmonology), the types of payments, and how they compare to peers. The largest payment category is general ($911.28). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Amanda Lewis?

The top pharmaceutical companies paying Amanda Lewis are: Merck & Co ($911.28). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Amanda Lewis receive?

Amanda Lewis's payments by type: general: $911.28.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Amanda Lewis's payments compare to other Pulmonology doctors?

To compare, look at the total amount ($911.28), number of payments (1), and the types of payments received. Pulmonology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Amanda Lewis's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1973962634). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Amanda Lewis's pharma payment profile?

The doctor's payment profile is highly concentrated, with 100% of the total amount coming from a single company. Amanda Lewis has received $911.28 in total pharma payments.

How does Amanda Lewis compare to peers in Pulmonology?

Compared to other Pulmonologists, Dr. Lewis's payment profile is less diverse, with a single payment from one company.

Are Amanda Lewis's pharma relationships typical for Pulmonology?

The data reflects only one payment, making it difficult to establish a comprehensive payment trend.

What should patients of Amanda Lewis know about these payments?

Consumers may wish to inquire about any potential influence on treatment decisions given the singular source of pharmaceutical payments.

What patterns are visible in Amanda Lewis's payment history?

The single payment is substantial ($911), suggesting a potentially significant engagement with the pharmaceutical company.

Understanding This Doctor Payment Report

This transparency report for Dr. Amanda Lewis is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Amanda Lewis's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Amanda Lewis and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.